These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 9728801

  • 1. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
    Vaiopoulos G, Boki K, Kapsimali V, Coulocheri S, Papadaki HA, Eliopoulos GD.
    Haematologia (Budap); 1998; 29(2):89-99. PubMed ID: 9728801
    [Abstract] [Full Text] [Related]

  • 2. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 3. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
    Ribbens C, André B, Kaye O, Kaiser MJ, Bonnet V, de Groote D, Franchimont N, Malaise MG.
    Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
    [Abstract] [Full Text] [Related]

  • 4. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1997 Dec; 45(5-6):449-53. PubMed ID: 9437501
    [Abstract] [Full Text] [Related]

  • 5. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR, Dawes PT, Nixon NB, Mattey DL.
    Arthritis Res Ther; 2005 Dec; 7(6):R1227-34. PubMed ID: 16277675
    [Abstract] [Full Text] [Related]

  • 6. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP, Liljeström M, Laiho K, Tiitinen S, Kaarela K, Hurme M.
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [Abstract] [Full Text] [Related]

  • 7. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR, Sanabria-Vera CJ, Romero-Adrián T.
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [Abstract] [Full Text] [Related]

  • 8. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]

  • 9. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
    Kacprzyk F.
    Pol Merkur Lekarski; 2003 Oct; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
    [Abstract] [Full Text] [Related]

  • 10. Elevated serum levels of TNF-alpha, sTNF-RI and sTNF-RII in murine schistosomiasis correlate with schistosome oviposition and circumoval granuloma formation.
    Haseeb MA, Shirazian DJ, Preis J.
    Cytokine; 2001 Sep 07; 15(5):266-9. PubMed ID: 11594791
    [Abstract] [Full Text] [Related]

  • 11. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA.
    J Rheumatol; 1997 Feb 07; 24(2):303-8. PubMed ID: 9034987
    [Abstract] [Full Text] [Related]

  • 12. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA, Dayer JM, Feldman BM, Pruzanski W, Roux-Lombard P, Schneider R, Laxer RM, Silverman ED.
    J Rheumatol; 2002 May 07; 29(5):1071-8. PubMed ID: 12022325
    [Abstract] [Full Text] [Related]

  • 13. Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure.
    Nozaki N, Yamaguchi S, Yamaoka M, Okuyama M, Nakamura H, Tomoike H.
    J Mol Cell Cardiol; 1998 Oct 07; 30(10):2003-12. PubMed ID: 9799654
    [Abstract] [Full Text] [Related]

  • 14. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
    Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Szymański L.
    Pol Merkur Lekarski; 2001 Jul 07; 11(61):19-25. PubMed ID: 11579824
    [Abstract] [Full Text] [Related]

  • 15. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
    Sumitomo M, Suda S, Shindo K, Fukumura M, Fukushima J, Okuda K, Ito A.
    Arerugi; 1997 Nov 07; 46(11):1136-47. PubMed ID: 9436331
    [Abstract] [Full Text] [Related]

  • 16. Both serum receptors of tumor necrosis factor are influenced by mud pack treatment in osteoarthrotic patients.
    Bellometti S, Galzigna L, Richelmi P, Gregotti C, Bertè F.
    Int J Tissue React; 2002 Nov 07; 24(2):57-64. PubMed ID: 12182234
    [Abstract] [Full Text] [Related]

  • 17. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
    Shen R, Xu CG, Li LZ, Zhang T, Qin XM, Li J, Zhao CL.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Apr 07; 25(4):209-12. PubMed ID: 15182557
    [Abstract] [Full Text] [Related]

  • 18. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S, Xiao H, Fan Y, Wu F, Zhang Z, Li H, Yang Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun 07; 25(6):325-9. PubMed ID: 12126553
    [Abstract] [Full Text] [Related]

  • 19. Cytokines and heart rate variability in patients with chronic heart failure.
    Straburzyńska-Migaj E, Ochotny R, Wachowiak-Baszyńska A, Straburzyńska-Lupa A, Leśniewska K, Wiktorowicz K, Cieśliński A.
    Kardiol Pol; 2005 Nov 07; 63(5):478-85; discussion 486-7. PubMed ID: 16362851
    [Abstract] [Full Text] [Related]

  • 20. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Nov 07; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.